Literature DB >> 9872331

Repression of Stat3 activity by activation of mitogen-activated protein kinase (MAPK).

N Jain1, T Zhang, S L Fong, C P Lim, X Cao.   

Abstract

STAT proteins are activated by phosphorylation at specific tyrosine residue at the carboxy-terminus which is required for dimer-formation, nuclear translocation, DNA binding and transcriptional activity in cells treated with cytokines and growth factors. Recent studies have indicated that STATs are also phosphorylated by MAPK, or extracellular signal-regulated kinase (ERK) on serine. We investigated the role of ERK on the regulation of STAT activity. Here, we report that ERK2 activated by its upstream kinase, MEK1, represses Stat3 transcriptional activity induced by Src or Jak-2. To unravel the mechanism of repression, we further showed that Stat3 DNA binding activity and its tyrosine phosphorylation are also inhibited under the same conditions. ERK2 phosphorylates Stat3 on three serine-containing peptides and decreases its tyrosine phosphorylation induced by EGF treatment. We also detected an association of ERK2 and Stat3 in vivo which is modulated positively by activation of ERK2, but negatively by Jak2. We propose that MAP kinase cascade may negatively regulate Stat3 activities by decreasing its tyrosine phosphorylation and also possibly by association.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9872331     DOI: 10.1038/sj.onc.1202238

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  58 in total

1.  Cytokine G-protein signaling crosstalk in cardiomyocytes: attenuation of Jak-STAT activation by endothelin-1.

Authors:  George W Booz; Jonathan N E Day; Robert Speth; Kenneth M Baker
Journal:  Mol Cell Biochem       Date:  2002-11       Impact factor: 3.396

2.  The JAK-STAT signaling network in the human B-cell: an extreme signaling pathway analysis.

Authors:  Jason A Papin; Bernhard O Palsson
Journal:  Biophys J       Date:  2004-07       Impact factor: 4.033

Review 3.  STAT signaling in polycystic kidney disease.

Authors:  Sebastian Strubl; Jacob A Torres; Alison K Spindt; Hannah Pellegrini; Max C Liebau; Thomas Weimbs
Journal:  Cell Signal       Date:  2020-04-20       Impact factor: 4.315

Review 4.  The biological functions of the versatile transcription factors STAT3 and STAT5 and new strategies for their targeted inhibition.

Authors:  Sylvane Desrivières; Christian Kunz; Itamar Barash; Vida Vafaizadeh; Corina Borghouts; Bernd Groner
Journal:  J Mammary Gland Biol Neoplasia       Date:  2006-01       Impact factor: 2.673

5.  Daphnetin reduces endotoxin lethality in mice and decreases LPS-induced inflammation in Raw264.7 cells via suppressing JAK/STATs activation and ROS production.

Authors:  Lei Shen; Ting Zhou; Jing Wang; Xiumei Sang; Lei Lan; Lan Luo; Zhimin Yin
Journal:  Inflamm Res       Date:  2017-04-13       Impact factor: 4.575

6.  Endothelin-1 impairs nitric oxide signaling in endothelial cells through a protein kinase Cdelta-dependent activation of STAT3 and decreased endothelial nitric oxide synthase expression.

Authors:  Neetu Sud; Stephen M Black
Journal:  DNA Cell Biol       Date:  2009-11       Impact factor: 3.311

7.  Helicobacter pylori CagA phosphorylation status determines the gp130-activated SHP2/ERK and JAK/STAT signal transduction pathways in gastric epithelial cells.

Authors:  In Ohk Lee; Jie Hyun Kim; Yeun Jung Choi; Michael H Pillinger; Seok-Yong Kim; Martin J Blaser; Yong Chan Lee
Journal:  J Biol Chem       Date:  2010-03-26       Impact factor: 5.157

8.  Suppressor of cytokine signaling-2 gene disruption promotes Apc(Min/+) tumorigenesis and activator protein-1 activation.

Authors:  Victoria A Newton; Nicole M Ramocki; Brooks P Scull; James G Simmons; Kirk McNaughton; P Kay Lund
Journal:  Am J Pathol       Date:  2010-03-26       Impact factor: 4.307

Review 9.  Role of signal transducer and activator of transcription 3 in neuronal survival and regeneration.

Authors:  Suzan Dziennis; Nabil J Alkayed
Journal:  Rev Neurosci       Date:  2008       Impact factor: 4.353

10.  Nifuroxazide inhibits survival of multiple myeloma cells by directly inhibiting STAT3.

Authors:  Erik A Nelson; Sarah R Walker; Alicia Kepich; Laurie B Gashin; Teru Hideshima; Hiroshi Ikeda; Dharminder Chauhan; Kenneth C Anderson; David A Frank
Journal:  Blood       Date:  2008-09-29       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.